The modified vaccinia Ankara-Bavarian Nordic mpox vaccine (MVA-BN; Jynneos) generated robust immune responses in adolescents ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

The Centers for Disease Control and Prevention (CDC) recommends everyone gets the updated 2024-2025 COVID-19 vaccines to ...

Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO® (Respiratory Syncytial Virus Vaccine), the company's bivalent RSV prefusion F (RSVpreF) vaccine, for ...

You'd hardly know it with the recent streak of summer weather, but we're weeks away from colder days when respiratory viruses ...

A group of U.S. senators are digging into the direct-to-consumer telehealth platforms launched by Eli Lilly and Pfizer this ...

Zylem Biosciences, a company specializing in cancer and cardiovascular therapeutics, announced that Northwestern University has filed a lawsuit against Moderna, alleging infringement of key patents ...

Thanks to mass immunization campaigns, by the year 2000, measles, once a common childhood illness with severe complications, ...

PFE's non-COVID drugs and potential contributions from new and newly acquired products have started to drive growth.

In addition, the FDA awarded an Orphan Products Development grant to support the evaluation of HyBryteTM for expanded treatment in patients with early-stage CTCL, including in the home use setting.

The global nanomedicine market is growing rapidly, driven by advances in nanotechnology-based drug delivery and personalized ...

The biotechnology giant has not ruled out expanding its pipeline of treatments through acquisitions after a number of ...